(Q36150828)

12 August 2017

1 reference

title

MRSA--what is it, and how do we deal with the problem? (English)

1 reference

12 August 2017

John F Barrett

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

Expert Opinion on Therapeutic Targets

12 August 2017

published in

1 reference

12 August 2017

volume

9

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

253-265

1 reference

Antibiotic resistance in Staphylococcus aureus: concerns, causes and cures

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Antibacterials: are the new entries enough to deal with the emerging resistance problems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Antibiotic resistance from two perspectives: man and microbe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

The threat from the pink corner

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Taking inventory: antibacterial agents currently at or beyond phase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

New (and not so new) antibacterial targets - from where and when will the novel drugs come?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

The abandonment of antibacterials: why and wherefore?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Staphylococcus aureus: superbug, super genome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

An international multicenter study of antimicrobial consumption and resistance in Staphylococcus aureus isolates from 15 hospitals in 14 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

The emergence and evolution of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Antimicrobial therapy of methicillin resistant Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Staphylococci in colonization and disease: prospective targets for drugs and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Nasal colonization by Staphylococcus aureus in active, independent, community seniors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Local variants of Staphylococcal cassette chromosome mec in sporadic methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococci: evidence of horizontal gene transfer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Resistance in the environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Predicting the evolution of antibiotic resistance genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Vancomycin resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Analysis on distribution and genomic diversity of high-level antiseptic resistance genes qacA and qacB in human clinical isolates of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Antibiotic treatment of gram-positive bone and joint infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Novel antibacterial agents for the treatment of serious Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Changes in staphylococcal cassette chromosome type and antibiotic resistance profile in methicillin-resistant Staphylococcus aureus isolates from a French hospital over an 11 year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Identification in Methicillin-Susceptible Staphylococcus hominis of an Active Primordial Mobile Genetic Element for the Staphylococcal Cassette Chromosome mec of Methicillin-Resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Antibiotic resistance in 3113 blood isolates of Staphylococcus aureus in 40 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2000-2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Clonal types and multidrug resistance patterns of methicillin-resistant Staphylococcus aureus (MRSA) recovered in Italy during the 1990s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Novel inhibitors of bacterial cell wall synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Antibiotic resistance in the intensive care unit setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Infective endocarditis: a review of the best treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Improvement of a latex agglutination test for the evaluation of oxacillin resistance in coagulase-negative staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

The Lowbury lecture: behaviour in infection control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Revolutionising hand hygiene in health-care settings: guidelines revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Antimicrobial resistance in the intensive care unit: understanding the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Epidemiology of methicillin-resistant staphylococci in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Oxazolidinones: activity, mode of action, and mechanism of resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Economic consequences of antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Community-associated methicillin-resistant Staphylococcus aureus: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Staphylococcal methicillin resistance: fine focus on folds and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

The changing face of antibiotic prescribing: the mutant selection window

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Antibiotic synergy and antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Novel anti-staphylococcal targets and compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Exploiting genomics to discover new antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Genetic strategies for antibacterial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Combating infectious diseases through multivalent design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

21 January 2018

Are all MRSA made equal?

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Bacterial Biofilms: An Emerging Link to Disease Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Evolvability is a selectable trait

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Molecular mechanisms that confer antibacterial drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Concentration-dependent changes in the susceptibility and killing of Staphylococcus aureus in an in vitro dynamic model that simulates normal and impaired gatifloxacin elimination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Whole genome sequencing of meticillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Antibacterial drug discovery in the post-genomics era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Regulation of the expression of cell wall stress stimulon member gene msrA1 in methicillin-susceptible or -resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Towards targeted prescribing: will the cure for antimicrobial resistance be specific, directed therapy through improved diagnostic testing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Lysostaphin Disrupts Staphylococcus aureus and Staphylococcus epidermidis Biofilms on Artificial Surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

CS-023 (R-115685), a novel carbapenem with enhanced in vitro activity against oxacillin-resistant staphylococci and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

Oritavancin and tigecycline: investigational antimicrobials for multidrug-resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

21 January 2018

Bacteriophage Therapy

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.2.253

21 January 2018

Identifiers

DOI

10.1517/14728222.9.2.253

1 reference

12 August 2017

1 reference